Medicine Description isorifa 150mg
Isorifa 150mg Capsule is a medication that contains rifampicin as its active ingredient, which is classified as a broad-spectrum antibiotic. The mechanism of action of rifampicin involves the inhibition of bacterial RNA synthesis. It achieves this by binding to the beta subunit of bacterial DNA-dependent RNA polymerase, which is essential for the transcription process in bacteria. By disrupting RNA synthesis, Isorifa effectively halts the growth and replication of Mycobacterium tuberculosis, the bacterium responsible for tuberculosis. This action not only helps in reducing the bacterial load in active tuberculosis cases but also plays a critical role in preventing the disease in individuals who have been exposed to the bacteria, making it a crucial component in both the treatment and prophylaxis of tuberculosis.
Indications and Uses of Isorifa 150mg Capsule
- Treatment of active tuberculosis in adults and children.
- Prevention of tuberculosis in individuals exposed to the pathogen.
- Part of combination therapy for multidrug-resistant tuberculosis.
Side Effects of Isorifa 150mg Capsule
- Nausea and vomiting.
- Loss of appetite.
- Abdominal pain.
- Fatigue.
- Skin rash or itching.
- Orange-red discoloration of bodily fluids, such as urine and sweat.
Storage and Handling
Store Isorifa 150mg Capsules at room temperature, away from direct sunlight and moisture. Keep out of reach of children and pets. Do not store in the bathroom.
Patient Advice and Precautions
Patients should be advised to take Isorifa exactly as prescribed and to complete the full course of therapy, even if symptoms improve. It is essential to inform healthcare providers about any other medications being taken to avoid potential interactions. Regular monitoring by a healthcare professional is recommended to assess liver function, as rifampicin may affect liver enzymes. Patients should also be informed about the possibility of discoloration of urine and other bodily fluids, which is a harmless side effect.